Hypertension Clinical Trials in Phoenix

Showing 101-107 of 107 trials

A Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension

NCT00325962

The purpose of this study is to determine whether 6R-BH4 (sapropterin dihydrochloride) is safe and effective in the treatment of poorly controlled hypertension in the presence or absence of type 2 diabetes.

Hypertension

BioMarin Pharmaceutical84 participantsStarted May 2006

Hoover, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +21 more locations

COMPLETEDPHASE3108 miles

PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension

NCT00125918

The purpose of this study is to evaluate the safety and effectiveness of tadalafil for the treatment of pulmonary arterial hypertension.

Pulmonary Hypertension

Eli Lilly and Company406 participantsStarted Aug 2005

Tucson, Arizona, United States • Minneapolis, Minnesota, United States • Salt Lake City, Utah, United States +3 more locations

A Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension

PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension

Hypertension Trials in Other Cities

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis

Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects

Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan

Other Conditions in Phoenix